81 – 90 of 155
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Goal-setting in Multidisciplinary Team Care for Patients with Rheumatoid Arthritis: An International Multi-centre Evaluation of the Contents Using the International Classification of Functioning, Disability and Health as a Reference
(
- Contribution to journal › Article
-
Mark
Healthcare consultation and sick leave before and after neck injury: a cohort study with matched population-based references.
(
- Contribution to journal › Article
-
Mark
Promoting work ability in a structured national rehabilitation program in patients with musculoskeletal disorders: outcomes and predictors in a prospective cohort study
(
- Contribution to journal › Article
-
Mark
Trends in the first decade of 21st century healthcare utilisation in a rheumatoid arthritis cohort compared with the general population.
(
- Contribution to journal › Article
-
Mark
Work productivity in a population-based cohort of patients with spondyloarthritis.
(
- Contribution to journal › Article
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
(
- Contribution to journal › Article
- 2012
-
Mark
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
(
- Contribution to journal › Article
-
Mark
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug.
(
- Contribution to journal › Article
-
Mark
Sick leave in patients with ankylosing spondylitis before and after anti-TNF therapy: a population-based cohort study.
(
- Contribution to journal › Article